Christopher D. Roberts, Chief Scientific Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 4,858 shares at $29.63 ($144K) on 2020-09-03, disclosed to the SEC on 2020-09-04.
Open-market sale of $144k BDTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.95 | 142 | $4K | 2.9% |
| 2 | $29.63 | 2,358 | $70K | 48.6% |
| 3 | $29.63 | 2,358 | $70K | 48.6% |
| Total | $29.61 avg | 4,858 | $144K | 100% |
| Filing → |
| BDTX | SELL | 2021-03-04 | $65K | — | Filing → |
| BDTX | SELL | 2021-02-04 | $63K | — | Filing → |
| BDTX | SELL | 2021-01-06 | $140K | — | Filing → |